1. Home
  2. BLFS vs EVO Comparison

BLFS vs EVO Comparison

Compare BLFS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$22.38

Market Cap

923.5M

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.15

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLFS
EVO
Founded
1987
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.5M
934.1M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
BLFS
EVO
Price
$22.38
$3.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$32.00
$7.00
AVG Volume (30 Days)
310.1K
74.4K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
77.27
N/A
EPS
N/A
N/A
Revenue
$96,214,000.00
N/A
Revenue This Year
$19.73
$1.37
Revenue Next Year
$17.82
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
16.97
N/A
52 Week Low
$17.86
$2.31
52 Week High
$29.57
$4.80

Technical Indicators

Market Signals
Indicator
BLFS
EVO
Relative Strength Index (RSI) 65.09 63.79
Support Level $21.35 $2.87
Resistance Level $23.15 $3.78
Average True Range (ATR) 0.85 0.09
MACD 0.37 0.10
Stochastic Oscillator 93.99 78.38

Price Performance

Historical Comparison
BLFS
EVO

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: